Verum Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.25M | Buy |
4,174
+3,463
| +487% | +$2.7M | 0.75% | 32 |
|
|
2025
Q1 | $587K | Buy |
711
+28
| +4% | +$23.1K | 0.16% | 71 |
|
|
2024
Q4 | $527K | Sell |
683
-65
| -9% | -$50.2K | 0.15% | 84 |
|
|
2024
Q3 | $662K | Buy |
748
+17
| +2% | +$15.1K | 0.19% | 72 |
|
|
2024
Q2 | $662K | Buy |
731
+11
| +2% | +$9.96K | 0.21% | 70 |
|
|
2024
Q1 | $560K | Sell |
720
-20
| -3% | -$15.6K | 0.2% | 77 |
|
|
2023
Q4 | $431K | Sell |
740
-15
| -2% | -$8.74K | 0.17% | 86 |
|
|
2023
Q3 | $406K | Buy |
755
+238
| +46% | +$128K | 0.18% | 82 |
|
|
2023
Q2 | $242K | Buy |
+517
| New | +$242K | 0.22% | 86 |
|
|
2023
Q1 | – | Sell |
-623
| Closed | -$228K | – | 67 |
|
|
2022
Q4 | $228K | Buy |
+623
| New | +$228K | 0.28% | 65 |
|